Document is current

Any future updates will be listed below

Safety and efficacy of venetoclax-azacitidine combined with low-dose Idarubicin and cytarabine regimens for the treatment of newly diagnosed acute myeloid leukemia patients compared to the standard chemotherapy: a propensity score-matched real-world single-center experience

Crossref DOI link: https://doi.org/10.1007/s00277-025-06653-y

Published Online: 2025-12-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark